Myocardial reperfusion injury: Etiology, mechanisms, and therapies

Journal of Extra-Corporeal Technology

Volumn 36, Issue 4, 2004, Pages 391-411

  Hoffman, John W ^a,b,c   Gilbert, Timothy B ^b   Poston, Robert S ^b   Silldorff, Erik P ^a  

^a TOWSON UNIVERSITY   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^c KANSAS CITY UNIVERSITY OF MEDICINE AND BIOSCIENCES   (United States)

Author keywords

Antioxidants; Apoptosis; Endothelium; Hypercontracture; Inflammation; Ischemia; Myocytes; Oxidative stress; Polymorphonuclear leukocytes; Reperfusion injury; Sodium calcium exchanger; Sodium proton exchanger

Indexed keywords

2 AMINOMETHYL 4 TERT BUTYL 6 PROPIONYLPHENOL; 2 [2 (TRIPHENOLPHOSPHONIO)ETHYL] 3,4 DIHYDRO 2,5,7,8 TETRAMETHYL 2H 1 BENZOPYRAN 6 OL BROMIDE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATE; ALLOPURINOL; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CASPASE; COPPER; CYCLOSPORIN A; CYSTEINE; CYTOCHROME C; DEFEROXAMINE; DIMERCAPROL; DIMETHYL SULFOXIDE; EGB 671; EMOXIPINE; FATTY ACID BINDING PROTEIN; GLUTATHIONE; INDAPAMIDE; MANGANESE; OXIPURINOL; OXYGEN RADICAL; PHYTIC ACID; PROANTHOCYANIDIN; PROPOFOL; SELENIUM; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZINC;

APOPTOSIS; BLOOD VESSEL OCCLUSION; CALCIUM CELL LEVEL; CELL DAMAGE; CELL DEATH; DISEASE COURSE; DRUG EFFECT; ENZYME ACTIVATION; HEART CONTRACTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HUMAN; LEUKOCYTE ACTIVATION; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; NONHUMAN; OXIDATIVE STRESS; PROTEIN SECRETION; REPERFUSION INJURY; REVIEW; RISK FACTOR; SODIUM CALCIUM EXCHANGE; SODIUM CELL LEVEL;

EID: 11444260282     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Review

References (177)

1. Guyton AC. Textbook of Medical Physiology. 8th ed. Philadelphia: W.B Saunders Company; 1991;240-3.
2. Reimer KA, Jennings RB. Myocardial ischemia, hypoxia, and infarction. In: Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE, eds. The Heart and Cardiovascular System. New York, NY: Raven Press Publishers; 1986.
3. + exchange system. Circ Res. 1994;74:794-805.
4. Yellon DM, Baxter GF. Protecting the ischaemic and reperfused myocardium in acute myocardial infarction: distant dream or near reality? Heart. 2000;83:381-7.
5. Kloner R, Ellis S, Lange R, Braunwald E. Studies of experimental coronary artery reperfusion: effects on infract size, myocardial function, biochemistry, ultrastructure, and microvascular damage. Circulation. 1983;68:I8-I15.
6. Baghelai K, Graham L, Wechsler A, Jakoi E. Phenylephrine induces delayed cardioprotection against necrosis without amelioration of stunning. Ann Thorac Surg. 1999;68:1219-24.
7. Ravingerova T, Slezak J, Tribulova N, Dzurba A, Uhrik B, Ziegelhoffer A. Free radicals contribute to high incidence of reperfusion induced arrhythmias in isolated rat heart. Life Sci. 1999;65:1927-30.
8. Toufeksian M, Boucher F, Pucheu S, et al. Effects of selenium deficiency on the response of cardiac tissue to ischemia and reperfusion. Toxicology. 2000;148:125-32.
9. Lefner JF, Granger N. Oxidative stress and cardiac disease. Am J Med. 2000;109:315-23.
10. Park J, Lucchesi B. Mechanisms of myocardial reperfusion injury. Ann Thorac Surg. 1999;68:1905-12.
11. Ambrosio G, Tritto I. Reperfusion injury: experimental evidence and clinical implications. Am Heart J. 1999;138:S69-75.
12. Verma S, Fedak PW, Weisel RD, et al. Fundamentals of reperfusion injury for the clinical cardiologist. Circulation. 2002;105:2332-6.
13. Reffeimann T, Hale SL, Dow JS, Kloner RA. No-reflow phenomenon persists long-term after ischemia/reperfusion in the rat and predicts infarct expansion. Circulation. 2004;108:2911-7.
14. Barandier C, Tanguy S, Pucheu S, Boucher F, De Leiris J. Effect of antioxidant trace elements on the response of cardiac tissue to oxidative stress. Ann NY Acad Sci. 1999;874:138-55.
15. Rezvani M, Barrans J, Dai K, Liew C. Apoptosis-related genes expressed in cardiovascular development and disease: an EST approach. Cardiovasc Res. 2000;45:621-9.
16. Linzbach AJ. Heart failure from the point of view of quantitative anatomy. Am J Cardiol. 1960;5:370-82.
17. Anversa P, Kajstura J. Ventricular myocytes are not terminally differentiated in the adult mammalian heart. Circ Res. 1998;83:1-14.
18. Beltrami AP, Urbanek K, Kajstura J, et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med. 2001;344:1750-7.
19. Simpson PJ, Lucchesi BR. Free radicals and myocardial ischemia and reperfusion injury. J Lab Clin Med. 1987;110:13-30.
20. Ma X, Gao F, Lopez B, Christopher T, Vinten-Johansen J. Peroxynitrate, a two-edged sword in post-ischemic myocardial injury-dichotomy of action in crystalloid- versus blood- perfused hearts. J Pharmacol Exp Ther. 2000;292:912-20.
21. Jones SP, Hoffmeyer MR, Sharp BS, Ho Y, Lefer DJ. Role of intracellular antioxidant enzymes after in vivo myocardial ischemia and reperfusion. Am J Physiol Heart Circ Physiol. 2003;284:H277-82.
22. Das DK, Maulik N. Antioxidant effectiveness in ischemia-reperfusion tissue injury. Methods Enzymol. 1994;233:601-10.
23. Ronson R, Nakamura M, Vinten-Johansen J. The cardiovascular effects and implications of peroxynitrite. Cardiovasc Res. 1999;44:47-59.
24. Ide T, Tsutsui H, Kinugawa S, et al. Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. Circ Res. 1999;85:357-63.
25. Masini E, Salvemini D, Ndisang JF, et al. Cardioprotective activity of endogenous and exogenous nitric oxide on ischemia reperfusion injury in isolated guinea pig hearts. Inflamm Res. 1999;48:561-8.
26. Galang N, Sasaki H, Maulik N. Apoptotic cell death during ischemia/reperfusion and its attenuation by antioxidant therapy. Toxicology. 2000;148:111-8.
27. Piper H, Garcia-Dorado D. Prime causes of rapid cardiomyocyte death during reperfusion. Ann Thorac Surg. 1999;68:1913-9.
28. Vermeiren G, Claeys M, Bockstaele B, et al. Reperfusion injury after focal myocardial ischemia: polymorphonuclear leukocyte activation and its clinical implications. Resuscitation. 2000;45:35-61.
29. Sawyer D, Colucci W. Mitochondrial oxidative stress in heart failure, "oxygen wastage" revisited. Circ Res. 2000;86:119-20.
30. Ide T, Tsutsui H, Kingugawa S, et al. Direct evidence for increased hydroxyl radicals originating from superoxide in failing myocardium. Circ Res. 2000;86:152-7.
31. Arroyo CM, Kramer JH, Leiboff RH, Mergner GW, Dickens BF, Weglicki WB. Spin trapping of oxygen and carbon-centered free radicals in ischemic canine myocardium. Free Radic Biol Med. 1987;3:313-6.
32. Squadrito G, Pryor W. Oxidative chemistry of nitric oxide: The roles of superoxide, peroxynitrate, and carbon dioxide. Free Radic Biol Med. 1998;25:392-403.
33. Dhalla N, Elmoselhi AB, Hata T, Makino N. Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc Res. 2000;47:446-56.
34. Jordan JE, Zhao Z, Vinten-Johansen J. The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc Res. 1999;43:860-78.
35. Vinten-Johansen J. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc Res. 2004;61:481-97.
36. Bardenheurer HJ, Weigand MA. Leukocyte endothelial interactions- a double edged sword. Cardiovasc Res. 1999;41:511-3.
37. Winn RK, Ramamoorthy C, Vedder NB, Sharar SR, Harlan JM. Leukocyte-endothelial cell interactions in ischemia-reperfusion injury. Ann NY Acad Sci. 1997;83:311-21.
38. Stangl V, Rodiger O, Frank T, et al. Influence of polymorphonuclear leukocytes and plasma on coronary vasomotion after ischemia. Ann Thorac Surg. 1999;68:442-6.
39. Vinten-Johansen J, Thourani V, Ronson R, et al. Broad-spectrum cardioprotection with adenosine. Ann Thorac Surg. 1999;68:1942-48.
40. Hayashi Y, Sawa Y, Fukuyama N, et al. Leukocyte-depleted terminal blood cardioplegia provides superior myocardial protective effects in association with myocardium-derived nitric oxide and peroxynitrate production for patients undergoing prolonged aortic crossclamping for more than 120 minutes. J Thorac Cardiovasc Surg. 2003;126:1813-21.
41. Szekely A, Heindl B, Zahler S, Conzen P, Becker B. Nonuniform behavior of intravenous anesthetics on postischemic adhesion of neutrophils in the guinea pig heart. Anesth Analg. 2000;90:1293-300.
42. Budde JM, Morris CD, Velez DA, et al. Reduction of infarct size and preservation of endothelial function by multidose intravenous adenosine during extended perfusion. J Surg Res. 2004;116:104-15.
43. Pohlman T, Harlan J. Adaptive responses of the endothelium to stress. J Surg Res. 2000;89:85-119.
44. DiCorleto PE, Gimbrone MA. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and Coronary Artery Disease. Philadelphia: Lippincott-Raven Publishers; 1996;387-97.
45. 2-integrins and immunoglobulin superfamily members in myocardial ischemia-reperfusion. Ann Thorac Surg. 1999;68:1920-3.
46. Collard CD, Lekowski R, Jordan JE, Stahl GL. Complement activation following oxidative stress. Mol Immunol. 1999;36:941-8.
47. Hansen PR. Role of neutrophils in myocardial ischemia and reperfusion. Circulation. 1995;91:1872-85.
48. Carden D, Granger D. Pathophysiology of ischemia-reperfusion injury. J Pathol. 2000;190:255-66.
49. Reiter R, Tan D. Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart. Cardiovasc Res. 2003;58:10-9.
50. Ferrari R, Ceconi C, Curello S, et al. Role of oxygen free radicals in ischemic reperfused myocardium. Am J Clin Nutr. 1991;53:215S-22S.
51. Gunther M, Sampath V, Caughey W. Potential roles of myoglobin autoxidation in myocardial ischemia-reperfusion injury. Free Radic Biol Med. 1999;26:1388-95.
52. Lentsch A, Ward P. Regulation of inflammatory vascular damage. J Pathol. 2000;190:244-54.
53. Harrison R. Structure and function of xanthine oxidoreductase: where are we now? Free Radic Biol Med. 2002;33:774-97.
54. Youker K, Beirne J, Lee J, Michael L, Smith C, Entman M. Time-dependent loss of Mac-1 from infiltrating neutrophils in the reperfused myocardium. J Immunol. 2000;164:2752-8.
55. Zhao ZQ, Nakamura M, Wang NP, et al. Reperfusion induces myocardial apoptotic cell death. Cardiovasc Res. 2000;45:651-60.
56. Gottlieb R, Engler R. Apoptosis in myocardial ischemia-reperfusion. Ann NY Acad Sci. 1999;874:412-26.
57. Evan G, Littlewood T. A matter of life and cell death. Science. 1998;281:1309-12.
58. Freude B, Masters T, Robicsek F, et al. Apoptosis is initiated by myocardial ischemia and executed during reperfusion. J Mol Cell Cardiol. 2000;32:197-208.
59. Kroemer G, Dallaporta B, Resche-Rigon M. The mitochondrial death/life regulator in apoptosis and necrosis. Ann Rev Physiol. 1998;60:619-42.
60. Sabbah HN, Sharov VG. Apoptosis in heart failure. Prog Cardiovasc Dis. 1998;40:549-62.
61. Adams J, Cory S. The Bcl-2 protein family: Arbiters of cell survival. Science. 1998;281:1322-6.
62. Thornberry N, Lazebnik Y. Caspases: Enemy within. Science. 1998;281:1312-6.
63. Leist M, Single B, Castoldi A, Kuhnle S, Nicotera P. Intracellular adenosine triphosphate (ATP) concentration: A switch in the decision between apoptosis and necrosis. J Exp Med. 1997;185:1481-6.
64. Takashi E, Ashraf M. Pathological assessment of myocardial cell necrosis and apoptosis after ischemia and reperfusion with molecular and morphological markers. J Mol Cell Cardiol. 2000;32:209-24.
65. Valen G. The basic biology of apoptosis and its implications for cardiac function and viability. Ann Thorac Surg. 2003;75:S656-60.
66. Watts JA, Kline JA. Bench to bedside: the role of mitochondrial medicine in the pathogenesis and treatment of cellular injury. Acad Emerg Med. 2003;10:985-97.
67. Borutaite V, Brown GC. Mitochondria in apoptosis of ischemic heart. FEBS Lett. 2003;541:1-5.
68. LeMasters J. The mitochondrial permeability transition and the calcium, oxygen, and pH paradoxes: one paradox after another. Cardiovasc Res. 1999;44:470-3.
69. Sommer J, Jennings R, Katz A, Fozzard H, Arnsdorf M, Gunn R. Principles in cardiovascular research. In: Fozzard H, Haber E, Jennings R. Katz A, eds. The Heart and Cardiovascular System. 2nd ed. New York: Raven Press. 1991:3-110.
70. Jiang X, Wang X. Cytochrome c promotes caspase-9 activation by inducing nucleotide binding to APAF-1. J Biol Chem. 2000;275:31199-203.
71. Cheng E, Kirsch D, Clem R, et al. Conversion of bcl-2 to a bax-like death effector by caspases. Science. 1997;278:1966-8.
72. Saleh A, Srinivasula S, Balir L, Robbins P, Alnemri E. Negative regulation of the Apaf-1 apoptosome by Hsp70. Nat Cell Biol. 2000;2:476-83.
73. Pandey P, Saleh A, Nakazawa A, et al. Negative regulation of cytochrome c-mediated oligomerization of Apaf-1 and activation of procaspase-9 by heat shock protein 90. Eur Mol Biol J. 2000;19:4310-22.
74. Susin S, Daugas E, Ravgnan L, et al. Two distinct pathways leading to nuclear apoptosis. J Exp Med. 2000;192:571-9.
75. Anversa P, Kajstura J. Myocyte cell death in the diseased heart. Circ Res. 1998;82:1231-3.
76. Reed J. Cytochrome c: Can't live with it-can't live without it. Cell. 1997;91:559-62.
77. Green D, Reed J. Mitochondria and apoptosis. Science. 1998;281:1309-12.
78. Kim G, Chun Y, Park J, Kim M. Role of apoptosis-inducing factor in myocardial cell death by ischemia-reperfusion. Biochem Biophys Res Commun. 2003;309:619-24.
79. Halestrap AP, Kerr PM, Javadov S, Woodfield KY. Elucidating the molecular mechanisms of the permeability transition pore and its role in reperfusion injury of the heart. Biochim Biophys Acta. 1998;1366:79-94.
80. Smith R, Porteous C, Coulter C, Murphy M. Selective targeting of an antioxidant to mitochondria. Eur J Biochem. 1999;263:709-1.6.
81. Fliss H, Gattinger D. Apoptosis in ischemic and reperfused rat myocardium. Circ Res. 1996;79:949-56.
82. Fliss H. Accelerated apoptosis in reperfused myocardium: Friend or foe? Basic Res Cardiol. 1998;93:90-3.
83. Condorelli G, Roncarate R, Ross J, et al. Heart-targeted overexpression of caspase 3 in mice increases infarct size and depresses cardiac function. Prot Natl Acad Sci USA. 2001;98:9977-82.
84. Chen Z, Chua CC, Ho YS, Hamdy RC, Chua BH. Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial ischemia-reperfusion injury. Am J Physiol. 2001;280:H2313-20.
85. Saraste A, Pulkki K, Kallajoki M, Henriksen K, Parvinen M, Voipio-Pulkki LM. Apoptosis in human acute myocardial infarction. Circulation. 1997;95:320-3.
86. Aebert H, Cornelius T, Birnbaum DE, Siegel AV, Rigger GA, Schunkert H. Induction of early immediate genes and programmed cell death following cardioplegic arrest in human hearts. Eur J Cardiothorac Surg. 1997;12:261-7.
87. Black SC, Huang JQ, Rezaiefar P. Co-localization of the cystein protease caspase-3 with apoptotic myocutes after in vivo myocardial ischemia and reperfusion in the rat. J Mol Cell Cardiol. 1998;30:733-42.
88. Avkiran M. Rational basis for use of sodium-hydrogen exchange inhibitors in myocardial ischemia. Am J Cardiol. 1999;83:10G-8G.
89. 2+- overload. J Cardiovasc Pharmacol. 2000;35:855-62.
90. Bosteels S, Matejovic P, Flameng W, Mubagwa K. Sodium influx via a non-selective pathway activated by the removal of extracellular divalent cations: possible role in calcium paradox. Cardiovasc Res. 1999;43:417-25.
91. Zimmerman AN, Hulsmann WC. Paradoxical influence of calcium ions on the permeability of the cell membrane of the rat heart. Nature. 1966;211:646-7.
92. Griffiths E, Halestrap A. Mitochondrial non-specific pores remain closed during cardiac ischemia, but open upon reperfusion. Biochem J. 1995;307:93-8.
93. 2+ overload. Cardiovasc Res. 1999;44:556-67.
94. Ray M, Srivastava S, Maitra SC, Dubey MP. The hamster heart is resistant to calcium paradox. Pharmacol Res. 2000;41:475-81.
95. Fabiato A. Two kinds of calcium-induced release of calcium from the sarcoplasmic reticulum of skinned cardiac cells. Adv Exp Med Biol. 1992;311:245-62.
96. + exchange in ischemia-reperfusion. Basic Res Cardiol. 1996;91:191-202.
97. Dennis S, Gervers W, Opie L. Protons in ischemia: Where do they come from; where do they go? J Mol Cell Cardiol. 1991;23:1077-86.
98. Levitsky J, Gurell D, Frishman W. Sodium ion/hydrogen ion exchange inhibition: A new pharmological approach to myocardial ischemia and reperfusion injury. J Clin Pharmacol. 1998;38:887-97.
99. Buerke M, Rupprecht H, vom Dahl J, et al. Sodium-hydrogen exchange inhibition: novel strategy to prevent myocardial injury following ischemia and reperfusion. Am J Cardiol. 1999;83:19G-22G.
100. + exchange inhibition on the in vivo damage induced by ischaemia reperfusion in the interventricular septum of the rabbit heart. Pharmacol Toxicol. 2000;86:222-7.
101. Ganote C, Vander Heide R. Irreversible injury of isolated adult rat myocytes, osmotic fragility during metabolic inhibition. Am J Pathol. 1988;132:212-22.
102. + exchange. Am J Physiol. 1995;268:H1531-9.
103. LeMasters JJ, Bond JM, Chacon E, et al. The pH paradox in ischemia-reperfusion injury to cardiac myocytes. EXS. 1996;76:99-114.
104. Galinanes M, Fowler AG. Role of clinical pathologies in myocardial injury following ischemia and reperfusion. Cardiovasc Res. 2004;61:512-21.
105. Hansen PR. Myocardial reperfusion injury: experimental evidence and clinical relevance. Eur Heart J. 1995;16:734-40.
106. Carvajal K, Hafidi M, Banos G. Myocardial damage due to ischemia and reperfusion in hypertriglyceridemic and hypertensive rats: participation of free radicals and calcium overload. J Hypertens. 1999;17:1607-16.
107. Venditti P, Masullo P, Agnisola C, Di Meo S. Effect of vitamin E on the response to ischemia-reperfusion of Langendorff heart preparations from hyperthyroid rats. Life Sci. 2000;8:697-708.
108. Azhar G, Gao W, Liu L, Wei J. Ischemia-reperfusion in the adult mouse heart influence of age. Exp Gerontol. 1999;34:699-714.
109. Marczin N, El-Habashi N, Hoare GS, Bundy RE, Yacoub M. Antioxidants in myocardial ischemia-reperfusion injury: therapeutic potential and basic mechanisms. Arch Biochem Biophys. 2003;420:222-36.
110. Maulik N, Engelman RM, Rousou JA, Flak JE, Deaton D, Das DK. Ischemic preconditioning reduces apoptosis by upregulating anti-death gene Bcl-2. Ciculation. 1999;100:II369-75.
111. Brigelius-Flohe R, Traber M. Vitamin E: function and metabolism. FASEB J. 1999;13:1145-55.
112. Lassnigg A, Punz A, Barber R, et al. Influence of intravenous vitamin E supplementation in cardiac surgery on oxidative stress: a double-blinded, randomized, controlled study. Br J Anaesth. 2003;90:148-54.
113. Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ. Use of antioxidants for the prevention of cardiovascular disease: meta-analysis of randomized trials. Lancet. 2003;361:2017-23.
114. Dusinovic S, Mijalkovic D, Saicic Z, et al. Antioxidative defense in human myocardial reperfusion injury. J Environ Pathol Oncol. 1998;17:281-4.
115. Dingchao H, Zhiduan Q, Liye H, Xiaodong F. The protective effect of high-dose ascorbic acid on myocardium against reperfusion injury during and after cardiopulmonary bypass. Cardiovasc Surg. 1994;42:276-8.
116. Ito H, Torii H, Suzuki T. A comparative study on defense systems for lipid peroxidation by free radicals in spontaneously hypertensive and normotensive rat myocardium. Comp Biochem Physiol B. 1992;103:37-40.
117. Michael LH, Zhang Z, Hartley CJ, Bolli R, Taylor AA, Entman ML. Thromboxane B2 in cardiac lymph. Effect of superoxide dismutase and catalase during myocardial ischemia and reperfusion. Cire Res. 1990;66:1040-4.
118. Bilzer M, Lauterburg B. Glutathione metabolism in activated human neutrophils: stimulation of glutathione synthesis and consumption of glutathione by reactive oxygen species. Eur J Clin Invest. 1991;21:316-22.
119. Ceconi C, Curello S, Cargnoni A, Boffa G, Ferrari R. Antioxidant protection against damage during cardiac ischemia and reperfusion: effect of dimercapto-propanol. Cardioscience. 1990;1:191-8.
120. Rudyk BI, Sabadyshin RA. The significance of the antioxidant properties of emoxipin in the combined treatment of patients with chronic heart failiure. Lik Sprava. 1992;4:25-8.
121. Srimani BN, Engleman RM, Jones R, Das DK. Protective role of intracoronary fatty acid binding protein in ischemic and reperfused myocardium. Circ Res. 1990;66:1535-43.
122. Boucher FR, Schatz CJ, Guez DM, deLeiris JG. Beneficial effect of indapamide in experimental myocardial ischemia. Am J Hypertens. 1992;5:22-5.
123. Blaustein A, Schine L, Brooks W, Fanburg B, Bing O. Influence of exogenerously generated oxidant species on myocardial function. Am J Physiol. 1989;250:H595-9.
124. Tosaki A, Droy-Lefair MT, Pali T, Das DK. Effects of SOD, catalase, and a novel antiarrhythmic drug, EGB 761, on reperfusion-induced arrhythmias in isolated rat hearts. Free Radic Biol Med. 1993;14:361-70.
125. Rao PS, Liu XK, Das DK, Weinstein GS, Tyras DH. Protection of ischemic heart from reperfusion injury by myo-inositol hexaphosphate, a natural antioxidant. Ann Thorac Surg. 1991;52:908-12.
126. Van der Kraaij A, Mostert L. Iron-load increases the susceptibility of rat hearts to oxygen reperfusion damage. Protection by antioxidant (+)-cyanidanol-3 and deferoxamine. Circulation. 1988;78:442-9.
127. Temsah R, Netticadan T, Chapman D, Takeda S, Mochizuki S, Dhalla N. Alterations in sarcoplasmic reticulum and gene expression in ischemic-reperfused rat heart. Am J Physiol. 1999;277:H584-94.
128. Kang YJ. The antioxidant function of metallothionein in the heart. Proc Soc Exp Biol Med. 1999;222:263-73.
129. St Legar A, Cochrane A, Moore F. Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet. 1979;1:1017-20.
130. Sato M, Maulik G, Ray P, Bagchi D, Das D. Cardioprotective effects of grape seed proanthocyanidin against ischemic reperfusion injury. J Mol Cell Cardiol. 1999;31:1289-97.
131. Cain BS, Harken AH, Meldrum DR. Therapeutic strategies to reduce TNF-a mediated cardiac contractile depression following ischemia and reperfusion. J Mol Cell Cardiol. 1999;31:931-47.
132. Zapolska-Downar D, Zapolska-Downar A, Bukowska H, Galka H, Naruszewicz M. Ibuprofen protects low density lipoproteins against oxidative modification. Life Sci. 1999;65:2289-303.
133. Kennedy TP, Rao NV, Noah W, et al. Ibuprofen prevents oxidant lung injury and in vitro lipid peroxidation by chelating iron. J Clin Invest. 1990;86:1565-73.
134. Javadov SA, Lim KH, Kerr PM, Suleiman M, Angelini GD, Halestrap AP. Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition. Cardiovasc Res. 2000;45:360-9.
135. Bernardi P. Mitochondrial transport of cations: channels, exchangers, and permeability transition. Physiol Rev. 1999;79:1127-55.
136. Roberts R, DeMello V, Sobel BE. Deleterious effects of methyl-predisone in patients with myocardial infarction. Circulation. 1976;53:1204-6.
137. Simpson P, Todd R, Fantone J, Mickelson J, Griffin J, Lucchesi B. Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mo1, anti-CD11b) that inhibits leukocyte adhesion. J Clin Invest. 1988;81:624-9.
138. Matheis G, Scholz M, Gerber J, Abdel-Rahman U, Wimmer-Greinecker G, Moritz A. Leukocyte filtration in the early reperfusion phase on cardiopulmonary bypass reduces myocardial injury. Perfusion. 2001;16:43-9.
139. Palatianos GM, Balentine G, Papadakis EG, et al. Neutrophil depletion reduces myocardial reperfusion injury. Ann Thorac Surg. 2004;77:956-61.
140. Downing S, Edmunds L. Release of vasoactive substances during cardiopulmonary bypass. Ann Thorac Surg. 1992;54:1236-43.
141. Hughes S, Williams T, Brain S. Evidence that endogenous nitric oxide modulates oedema formation induced by substance P. Eur J Pharmacol. 1990;191:481-4.
142. Ialenti A, Ianaro A, Moncada S, Di Rosa M. Modulation of acute inflammation by endogenous nitric oxide. Eur J Pharmacol. 1992;211:177-82.
143. Wehberg K, Foster A, Wise R, McLaughlin J, Brunner M. Nitric oxide mediates fluid accumulation during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1996;112:168-74.
144. Inserte J, Garcia-Dorado D, Agullo L, Paniagaua A, Soler-Soler J. Urodilatin limits acute reperfusion injury in isolated rat hearts. Cardiovasc Res. 2000;45:351-9.
145. 3 adenosine receptor attenuates neutrophil function and neutrophil-mediated reperfusion injury. Am J Physiol. 1999;46:H1895-905.
146. Olafsson B, Forman M, Puett D, et al. Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: Importance of endothelium and the no-reflow phenomenon. Circulation. 1987;76:1135-45.
147. Pitarys C, Virmani R, Vildibill H, Jackson E, Forman M. Reduction of myocardial reperfusion by intravenous adenosine administered during the earlu reperfusion period. Circulation. 1991;83:237-47.
148. Chauhan S, Wasir HS, Bhan A, Rao BH, Saxena N, Venugopal P. Adenosine for cardioplegic induction: a comparison with St. Thomas solution. J Cardiothorac Vasc Anesth. 2000;14:21-4.
149. Mentzer RM, Birjiniuk V, Khuri S, et al. Adenosine myocardial protection preliminary results of a phase II clinical trial. Ann Surg. 1999;229:643-50.
150. Boyle E, Canty T, Morgan E, Yun W, Pohlman T, Verrier E. Treating myocardial ischemia-reperfusion injury by targeting endothelial cell transcription. Ann Thorac Surg. 1999;68:1949-53.
151. Theroux P. Protection of the myocardial cell during ischemia. Am J Cardiol. 1999;83:3G-9G.
152. Mocanu MM, Baxter GF, Yellon DM. Caspase inhibition and limitation of myocardial infarct size: protection against lethal reperfusion injury. Br J Pharmacol. 2000;130:197-200.
153. Musat-Marcu S, Gunter H, Jugdutt B, Docherty J. Inhibition of apoptosis after ischemia-reperfusion in rat myocardium by cycloheximide. J Mol Cell Cardiol. 1999;31:1073-82.
154. Gumina R, Mizumra T, Beier N, Schelling P, Schultz J, Gross G. A new sodium/hydrogen exchange inhibitor, EMD 85131, limits infarct size in dogs when administered before or after coronary artery occlusion. J Pharmacol Exp Ther. 1998;286: 175-83.
155. Linz WJ, Busch AE. NHE-1 inhibition: from protection during acute ischaemia/reperfusion to prevention/reversal of myocardial remodeling. Naunyn Schmiedebergs Arch Pharmacol. 2003;368:239-46.
156. Stromer H, de Groot MC, Horn M, et al. Na+/H+ exchange inhibition with HOE642 improves postischemic recovery due to attenuation of Ca2+ overload and prolonged acidosis on reperfusion. Circulation. 2000;101:2749-55.
157. Karmazyn M. The role of the myocardial sodium-hydrogen exchanger in mediating ischemic and reperfusion injury from amiloride to cariporide. Ann NY Acad Sci. 1999;874:326-34.
158. + exchange regulation and the role of the exchanger in hypertension and cardiac function in health and disease. Cardiovasc Res. 1997;36:138-48.
159. Mentzer RM, Lasley RD, Jessel A, Karmazyn M. Intracellular sodium hydrogen exchange inhibition and clinical myocardial protection. Ann Thorac Surg. 2003;75:S700-8.
160. Boyce SW, Bartels C, Bolli R, et al. Impact of sodium-hydrogen exchange inhibition by cariporide on death or myocardial infarction in high-rish CABG surgery patients: results of the CABG surgery cohort of the GUARDIAN study. J Thorac Cardiovasc Surg. 2003;126:420-7.
161. Allen DG, Xiao X. Role of cardiac Na+/H+ exchanger during ischemia and reperfusion. Cardiovasc Res. 2003;57:934-41.
162. Castella M, Buckberg GD, Saleh S, Tan Z, Ignarro L. A new role for cardioplegic buffering: should acidosis or calcium accumulation be counteracted to salvage jeopardized hearts? J Thorac Cardiovasc Surg. 2003;126:1442-8.
163. Castella M, Buckberg GD, Tan Z. Blood cardioplegic protection in profoundly damaged hearts: role of Na+-H+ exchange inhibition during pretreatment or during controlled reperfusion supplementation. Ann Thorac Surg. 2003;75:1238-45.
164. Muraki S, Morris CD, Budde JM, Zhao Z, Guyton RA, Vinten-Johansen J. Blood cardioplegia supplementation with the sodium-hydrogen ion inhibitor cariporide to attenuate infarct size and coronary artery endothelial dysfunction after severe regional ischemia in a canine model. J Thorac Cardiovasc Surg. 2003;125:155-64.
165. Camara AK, An J, Chen Q, et al. Na+/H+ exchange inhibition with cardioplegia reduces cytosolic [Ca2+] and myocardial damage after cold ischemia. J Cardiovasc Pharmacol. 2003;41:686-98.
166. Klass O, Fischer UM, Perze E, et al. Effect of the Na+/H+ exchange inhibitor eniporide on cardiac performance and myocardial high energy phosphates in pigs subjected to cardioplegic arrest. Ann Thorac Surg. 2004;77:658-63.
167. Ohtsuka M, Takano H, Suzuki M, et al. Role of Na+-Ca2+ exchanger in myocardial ischemia/reperfusion injury: evaluation using a heterozygous Na+-Ca2+ exchanger knockout mouse model. Biochem Biophys Res Commun. 2004;314:849-53.
168. 2+ exchanger and myocardial ischemia/reperfusion. Jpn Heart J. 1998;39:707-14.
169. 2+ after reperfusion: a study with monensin and dichlorobenzamil. Jpn J Pharmacol. 1992;59:191-200.
170. Schafer C, Ladilov Y, Inserte J, et al. Role of the reverse mode of the Na+/Ca2+ exchanger in reoxygenation-induced cardiomyocyte injury. Cardiovasc Res. 2001;51:241-50.
171. Gross G, Auchampach J. Role of ATP dependent potassium channels in myocardial ischemia. Cardiovasc Res. 1992;26:1011-6.
172. 2+-transients and intracellular pH in cultured cardiac myocytes. J Mol Cell Cardiol. 1993;25:599-613.
173. Preckel B, Schlack W, Comfere T, Thamer V. Effect of dantrolene in an in vivo and in vitro model of myocardial reperfusion injury. Acat Anaesthesiol Scand. 2000;44:194-201.
174. Fuchs F, Messmer K, Kuppe H, Habazettl H. Initial reperfusion with magnesium after cardioplegic arrest attenuates myocardial reperfusion injury. Thorac Cardiovasc Surg. 2002;50:208-15.
175. th scientific sessions of the American College of Cardiology. Circulation. 1999;100:570-5.
176. Komori S, Li B, Matsumura K, et al. Antiarrhythmic effect of magnesium sulfate against occlusion-induced arrhythmias and reperfusion-induced arrhythmias in anesthetized rats. Mol Cell Biochem. 1999;199:201-8.
177. Garcia LA, Dejong SC, Martin SM, Smith RS, Buettner GR, Kerber RE. Magnesium reduces free radicals in an in vitro coronary occlusion-reperfusion model. J Am Coll Cardiol. 1998;32:536-9.